suppl_file.pdf (59.18 kB)
Supplementary Figure 1. Substantial remission of Prostate Adenocarcinoma with Dendritic Cell therapy APCEDEN® in combination with chemotherapy
figure
posted on 2019-10-31, 16:14 authored by Chaitanya Kumar Thota, Jasmine Bagga, Srikanth Chiliveru, Sakshi Kohli, Asmi Bharadwaj, Minish Jain, Shriram Inamdar, Bandana SharanSupplementary Figure 1. Substantial remission of Prostate Adenocarcinoma with Dendritic Cell therapy APCEDEN® in combination with chemotherapy
Phenotypic assessment of dendritic cells before packaging of six doses of APCEDEN® treatment.
History
Usage metrics
Categories
Keywords
Prostate adenocarcinomaImmunotherapyAPCEDEN®Dendritic cellsinterferon gammaIFNγNeutrophil lymphocyte ratioNLRPlatelet lymphocyte ratioPLRTregRegulatory T CellsNephrology and UrologyApplied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)Cancer Therapy (excl. Chemotherapy and Radiation Therapy)
